Table 1.

Summarization of abbreviations and their full name.

Abbreviation	Full name
SCLC	Small cell lung cancer
NSCLC	Non-small cell lung cancer
LUAD	Lung adenocarcinoma
LSCC	Lung squamous cell carcinoma
LLCC	Lung large cell carcinoma
CCRT	Concurrent chemoradiotherapy
PD-1	Programmed death 1
PD-L1	Programmed death 1 ligand
CTLA-4	Cytotoxic-T-lymphocyte-associated protein 4
anti-PD-1	Anti-programmed death 1
anti-PD-L1	Anti-programmed death 1 ligand
anti-CTLA-4	Anti-cytotoxic-T-lymphocyte-associated protein 4
FDA	Food and Drug Administration
ORR	Overall response rate
OS	Overall survival
PFS	Progression-free survival
EGFR	Epidermal growth factor receptor
ALK	Anaplastic lymphoma kinase
TMB	Tumor mutation burden
mut/Mb	Mutations/megabase
IV	Intravenously
TMB-H	TMB-high
ES-SCLC	Extensive-stage SCLC
ICIs	Immune checkpoint inhibitors
WES	Whole exome sequencing
MMR	Mismatch repair
MSI	Microsatellite instability
dMMR	MMR deficiency
VAF	Variant allele fraction
bTMB	Blood TMB
ctDNA	Circulating tumor DNA
TILs	Tumor infiltrating lymphocytes
QIF	Quantitative immunofluorescence
SCFAs	Short chain fatty acids
TME	Tumor microenvironment
CAR-T	Chimeric antigen receptor T
NSqNSCLC	nonsquamous non-small-cell lung cancer
nab	nano-particle albumin-bound
ECOG	Eastern Cooperative Oncology Group
TPS	Tumor Proportion Score